- Filed
- May 6, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · Apr 27, 2026 | 86.53M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 90.17M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2025 | 79.89M sh |
| Capex | Q1 2026 · Mar 31, 2026 | $5.18M |
| Capex restated | Q1 2026 · Mar 31, 2025 | $2.61M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | $3.89M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2025 | −$246K |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $58.72M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2025 | $34.83M |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | $285.73M |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | $279.07M |
| Stockholders Equity | Q1 2026 · Mar 31, 2025 | $219.73M |
| Stockholders Equity | Q1 2026 · Dec 31, 2024 | $221.94M |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $20.94M |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $19.79M |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $41.89M |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $46.4M |
| Current Assets | Q1 2026 · Mar 31, 2026 | $124.15M |
| Current Assets | Q1 2026 · Dec 31, 2025 | $126.19M |
| Total Assets | Q1 2026 · Mar 31, 2026 | $327.62M |
| Total Assets | Q1 2026 · Dec 31, 2025 | $325.47M |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | $0.03 |
| Eps Diluted | Q1 2026 · Mar 31, 2025 | −$0.04 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | $0.03 |
| Eps Basic | Q1 2026 · Mar 31, 2025 | −$0.04 |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $15.61M |
| Sga Expense | Q1 2026 · Mar 31, 2025 | $12.33M |
| Net Income | Q1 2026 · Mar 31, 2026 | $2.15M |
| Net Income | Q1 2026 · Mar 31, 2025 | −$3.49M |
| Operating Income | Q1 2026 · Mar 31, 2026 | −$2.97M |
| Operating Income restated | Q1 2026 · Mar 31, 2025 | −$5.69M |
| Gross Profit | Q1 2026 · Mar 31, 2026 | $14.12M |
| Gross Profit | Q1 2026 · Mar 31, 2025 | $7.05M |
| Cost Of Revenue | Q1 2026 · Mar 31, 2026 | $53.27M |
| Cost Of Revenue restated | Q1 2026 · Mar 31, 2025 | $28.9M |
| Revenue | Q1 2026 · Mar 31, 2026 | $67.38M |
| Revenue restated | Q1 2026 · Mar 31, 2025 | $35.95M |